Dr. Matthew Brock, D.O
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $451.16 | 23 | 97.5% |
| Education | $11.56 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $176.13 | 7 | $0 (2020) |
| Novo Nordisk Inc | $82.89 | 5 | $0 (2020) |
| Lilly USA, LLC | $64.76 | 4 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $39.52 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $35.61 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $27.99 | 2 | $0 (2021) |
| Shire North American Group Inc | $22.78 | 1 | $0 (2019) |
| Genentech USA, Inc. | $13.04 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11.56 | 1 | AstraZeneca Pharmaceuticals LP ($11.56) |
| 2020 | $362.68 | 18 | PFIZER INC. ($176.13) |
| 2019 | $88.48 | 5 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($39.52) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 12/02/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/21/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Diabetes | ||||||
| 10/14/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/30/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: GASTROINTESTINAL | ||||||
| 09/02/2020 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 08/26/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Diabetes | ||||||
| 08/16/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes | ||||||
| 06/26/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Diabetes | ||||||
| 06/12/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/09/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Diabetes | ||||||
| 06/01/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: GASTROINTESTINAL | ||||||
| 05/06/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/29/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 02/13/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $87.27 | General |
| Category: GASTROINTESTINAL | ||||||
| 02/13/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: GASTROINTESTINAL | ||||||
| 01/25/2020 | PFIZER INC. | CHANTIX (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/10/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Diabetes | ||||||
| 12/11/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Diabetes | ||||||
| 06/13/2019 | Shire North American Group Inc | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: GENETIC DISEASE | ||||||
| 03/28/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.06 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/08/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.46 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/18/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 9 | 381 | 615 | $138,355 | $33,067 |
| 2021 | 10 | 360 | 634 | $142,909 | $40,031 |
| 2020 | 9 | 405 | 703 | $115,895 | $30,572 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 316 | $100,488 | $22,871 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 60 | $12,720 | $3,875 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $14,760 | $2,701 | 18.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 29 | 29 | $2,900 | $1,897 | 65.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 16 | 18 | $2,862 | $668.28 | 23.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 38 | 63 | $2,994 | $557.90 | 18.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 28 | $280.00 | $274.40 | 98.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 27 | 39 | $551.00 | $128.13 | 23.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 26 | 32 | $800.00 | $94.65 | 11.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 134 | 357 | $113,526 | $30,663 | 27.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 40 | 40 | $4,000 | $2,657 | 66.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $11,316 | $2,570 | 22.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 19 | $4,028 | $1,136 | 28.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 18 | 21 | $3,339 | $759.52 | 22.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 38 | 77 | $3,234 | $747.67 | 23.1% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 15 | 15 | $1,485 | $555.30 | 37.4% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 12 | 12 | $1,188 | $444.24 | 37.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 38 | 39 | $390.00 | $390.00 | 100.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 25 | 31 | $403.00 | $107.88 | 26.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 143 | 370 | $69,930 | $17,273 | 24.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 79 | $21,962 | $5,040 | 22.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 27 | 27 | $7,992 | $2,951 | 36.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 42 | 43 | $3,225 | $2,598 | 80.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $4,708 | $1,039 | 22.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 45 | 45 | $1,440 | $707.85 | 49.2% |
About Dr. Matthew Brock, D.O
Dr. Matthew Brock, D.O is a Student in an Organized Health Care Education/Training Program healthcare provider based in Shelbyville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2011. The National Provider Identifier (NPI) number assigned to this provider is 1275811077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Brock, D.O has received a total of $462.72 in payments from pharmaceutical and medical device companies, with $11.56 received in 2021. These payments were reported across 24 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($451.16).
As a Medicare-enrolled provider, Brock has provided services to 1,146 Medicare beneficiaries, totaling 1,952 services with total Medicare billing of $103,670. Data is available for 3 years (2020–2022), covering 28 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Shelbyville, TN
- Active Since 07/27/2011
- Last Updated 03/21/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1275811077
Products in Payments
- COLOGUARD (Device) $135.31
- Ozempic (Drug) $57.89
- TRULICITY (Drug) $44.44
- CHANTIX (Drug) $40.82
- LifeVest (Device) $39.52
- XARELTO (Drug) $35.61
- RYBELSUS (Drug) $25.00
- TAKHZYRO (Biological) $22.78
- JARDIANCE (Drug) $20.32
- FARXIGA (Drug) $16.43
- Xofluza (Drug) $13.04
- BREZTRI (Drug) $11.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Shelbyville
Melanie Stevens, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,898
Vincent Gemma, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $2,930
Meghan Roby, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $2,121
David Picklesimer, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1,587
Tia Alton, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $429.02
Bryant Dawson, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $141.65